ArticleMagnetic resonance in medicine2025
Amide mapping in the human brain using downfield MRSI at 3 T and 7 T.
Article in Magnetic resonance in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Downfield magnetic resonance signals serve as endogenous imaging biomarkers of nucleotide metabolism in glioma.Communications biology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
purposeTo quantitatively compare signal-to-noise ratios (SNRs), linewidth values, and Cramér-Rao lower bounds (CRLBs) for amide resonances in the human brain measured at 3T and 7T using downfield MR spectroscopic imaging (DF-MRSI).
methodsSeven normal volunteers (25-52 years, 5 female) were imaged using Philips 3T Elition and 7T Achieva scanners. Both systems have 32-channel receive head coils and 16-channel local shim arrays (MRShim GmbH) in addition to high-order spherical harmonic shims. Three-dimensional DF-MRSI data were collected using a previously developed pulse sequence with spectral-spatial excitation and frequency-selective refocusing pulses. Matched imaging protocols on both field strengths were applied to achieve a nominal voxel size of 7 × 7 × 15 mm in a scan time of 10.6 min. Spectral analysis was performed using the "LCModel" software package. SNR and CRLB values (%) were compared between 3T and 7T data using univariate general linear models.
resultsSignificantly increased amide SNR and decreased CRLB values (p < 0.05) were found at 7T. Averaged over all brain regions, SNR was 2.9 ± 1.1 at 3T and 5.4 ± 1.5 at 7T, and CRLBs were 11.4 ± 3.9 and 4.9 ± 1.5 respectively. 7T MRI and amide images did show some regional signal dropoff due to transmit B
conclusionThree-dimensional DF-MRSI at 7T showed 86% increased SNR and 57% decreased CRLB values compared with 3T, confirming the expected improvements at higher field. Improvements are probably due to multiple factors, including higher magnetization at 7T, the shorter minimum echo time available, among others.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.